HomeOthersINDIRA IVF DOUBLES NUMBER OF SUCCESSFUL IVF PREGNANCIES IN THREE YEARS

INDIRA IVF DOUBLES NUMBER OF SUCCESSFUL IVF PREGNANCIES IN THREE YEARS

~Market leader in single-speciality infertility treatment hospitals achieves India-first milestone of 150,000 successful IVF pregnancies~

~Over 140 centres serving across 22 states in the country~

Chandigarh, 19 June 2024: India’s largest network of infertility treatment hospitals, Indira IVF, announced the completion of 150,000 successful IVF pregnancies today, noting a 2x growth in the number of successful pregnancies in a span of three years. The milestone was achieved by adding 40 new centres in India in the same duration, increasing accessibility to more tier II and tier III locations in the country.

Starting as a stand-alone hospital in Udaipur in 2011, Indira IVF completed 75,000 successful IVF pregnancies with 94 centres in 2021 thus, noting a 100% increase in pregnancies with a 42% increase in footprint till date. This has been fuelled by a debt-free model, trained human capital of 2,700 professionals and implementation of advanced technology such as artificial intelligence, ensuring that 7 out of 10 couples on an average walk away with a positive pregnancy test.

A key driver of Indira IVF’s success is also its data-driven research approach. Indira IVF leverages its high patient volume to analyse vast amounts of data, uncovering key causes and triggers of infertility. Moreover, West Bengal has noted the highest incidences of male infertility, with 61% of the total couples treated having abnormal sperm parameters. In another retrospective study conducted with Indira IVF patient cases on Anti-Müllerian Hormone (AMH) – a hormone used as a biomarker to evaluate ovarian reserve in females – found that south Indian states have higher median AMH levels than other zones of the country.

This data-driven approach by Indira IVF serves multiple strategic aims – to gain deeper insights into the root causes and triggers of infertility across India, optimize and enhance their treatment protocols for improved success rates, maintain leadership by continually advancing medical practices based on evidence, increase accessibility by understanding geographic variations, and drive operational efficiency. Such a data-driven approach thus, fuels its success rates and operational efficiency, connecting with the company’s commitment to continuously advancing practices and ensuring the highest standards of patient care.

Speaking on Indira IVF’s success, Mr Nitiz Murdia – Managing Director and Co-Founder of Indira IVF said, “Achieving the milestone of 150,000 successful IVF pregnancies is a tremendous achievement, and it wouldn’t have been possible without the dedication and expertise of our entire team. We are incredibly grateful for the trust our patients have placed in us. As leaders in the industry, this milestone is also a reminder that responsibility lies in continuously advancing our practices, ensuring the highest standards of patient care, and fostering a supportive and ethical environment for all those we serve.

Highlighting the company’s future aspirations, Dr Kshitiz Murdia – CEO & Co-Founder of Indira IVF said, “Achieving 150,000 successful IVF pregnancies is a remarkable milestone for us. Our goal is to create a success story for every patient who walks into an Indira IVF Clinic. As leaders in the industry, we recognize our social responsibility and commit ourselves to sustainability with each milestone. Our efforts aim to contribute to a healthier and more equitable world. By integrating these values into our mission, we strive to make a positive impact not only for our patients but also for the broader community and future generations”.

Indira IVF’s unwavering commitment to patient care, cutting-edge technology, and accessibility has positioned the company as a leader in India’s infertility treatment landscape. The company’s geographical expansion is on track to grow to 300 centres in India in the next three years with a strong focus on continued innovation, and sustainability.

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular